Literature DB >> 2448300

Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain.

E A McGuire1, M E Peacock, R C Inhorn, N R Siegel, D M Tollefsen.   

Abstract

Incubation of human plasma with 27 nM [gamma-32P]ATP in the presence of 20 mM MnCl2 results in the phosphorylation of several proteins detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. About 60% of the incorporated radioactivity is found in a 75-kDa protein containing [32P] phosphoserine. The amino-terminal amino acid sequence of the purified 75-kDa [32P]phosphoprotein is identical to that of vitronectin (also termed serum spreading factor or complement S protein). Rabbit antiserum against vitronectin precipitates greater than 90% of the 75-kDa [32P]phosphoprotein from plasma. Reverse phase chromatography of [32P]vitronectin degraded sequentially with CNBr and chymotrypsin yields one major labeled peptide. The sequence of the peptide, Ser-Arg-Arg-Pro-[32PO4]Ser-Arg-Ala-Thr, corresponds to residues 374-381 which are located in the heparin-binding fragment of vitronectin identified by Suzuki et al. [1984) J. Biol. Chem. 259, 15307-15314). Vitronectin could potentially be phosphorylated in vivo with ATP released from injured cells or secreted by platelets activated during hemostasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448300

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 2.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

3.  Phosphorylation of complement factor C3 in vivo.

Authors:  S C Martin
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

4.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.

Authors:  J I Jones; A J D'Ercole; C Camacho-Hubner; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.

Authors:  T J Girard; D McCourt; W F Novotny; L A MacPhail; K M Likert; G J Broze
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

6.  Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.

Authors:  M Weller; P Wiedemann; M Bresgen; K Heimann
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

7.  The human vitronectin (complement S-protein) gene maps to the centromeric region of 17q.

Authors:  T M Fink; D E Jenne; P Lichter
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.